Cargando…
Gain-of-function mutant p53 in cancer progression and therapy
p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite for cancer development. The p53 gene is the most frequently mutated gene in human cancers; p53 mutations occur in >50% of all human cancers and in almost every type of human cancers. Most of p53 mutations in canc...
Autores principales: | Zhang, Cen, Liu, Juan, Xu, Dandan, Zhang, Tianliang, Hu, Wenwei, Feng, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749743/ https://www.ncbi.nlm.nih.gov/pubmed/32722796 http://dx.doi.org/10.1093/jmcb/mjaa040 |
Ejemplares similares
-
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
por: Liu, Juan, et al.
Publicado: (2023) -
The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
por: Zhang, Cen, et al.
Publicado: (2021) -
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013) -
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression
por: Yue, Xuetian, et al.
Publicado: (2017) -
Tumor suppressor p53 and metabolism
por: Liu, Juan, et al.
Publicado: (2018)